Literature DB >> 31145433

A Cross-Sectional Analysis of Telomere Length and Sleep in the Women's Health Initiative.

Laurie Grieshober1,2, Jean Wactawski-Wende1, Rachael Hageman Blair3, Lina Mu1, Jingmin Liu4, Jing Nie1, Cara L Carty4, Lauren Hale5, Candyce H Kroenke6, Andrea Z LaCroix7, Alex P Reiner4,8, Heather M Ochs-Balcom1.   

Abstract

Telomere length is a heritable marker of cellular age that is associated with morbidity and mortality. Poor sleep behaviors, which are also associated with adverse health events, may be related to leukocyte telomere length (LTL). We studied a subpopulation of 3,145 postmenopausal women (1,796 European-American (EA) and 1,349 African-American (AA)) enrolled in the Women's Health Initiative in 1993-1998 with data on Southern blot-measured LTL and self-reported usual sleep duration and sleep disturbance. LTL-sleep associations were analyzed separately for duration and disturbance using weighted and confounder-adjusted linear regression models in the entire sample (AAs + EAs; adjusted for race/ethnicity) and in racial/ethnic strata, since LTL differs by ancestry. After adjustment for covariates, each additional daily hour of sleep beyond 5 hours, approximately, was associated with a 27-base-pair (95% confidence interval (CI): 6, 48) longer LTL in the entire sample. Associations between sleep duration and LTL were strongest among AAs (adjusted β = 37, 95% CI: 4, 70); a similar, nonsignificant association was observed for EAs (adjusted β = 20, 95% CI: -7, 48). Sleep disturbance was not associated with LTL in our study. Our models did not show departure from linearity (quadratic sleep terms: P ≥ 0.55). Our results suggest that longer sleep duration is associated with longer LTL in postmenopausal women.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Women’s Health Initiative; sleep; sleep disturbance; sleep duration; telomere length

Mesh:

Year:  2019        PMID: 31145433      PMCID: PMC6736371          DOI: 10.1093/aje/kwz134

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  77 in total

1.  Socioeconomic status and health: the role of sleep.

Authors:  Philip J Moore; Nancy E Adler; David R Williams; James S Jackson
Journal:  Psychosom Med       Date:  2002 Mar-Apr       Impact factor: 4.312

2.  Obesity, cigarette smoking, and telomere length in women.

Authors:  A M Valdes; T Andrew; J P Gardner; M Kimura; E Oelsner; L F Cherkas; A Aviv; T D Spector
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

3.  The pattern of chromosome-specific variations in telomere length in humans shows signs of heritability and is maintained through life.

Authors:  J Graakjaer; J A Londono-Vallejo; K Christensen; S Kølvraa
Journal:  Ann N Y Acad Sci       Date:  2006-05       Impact factor: 5.691

4.  Telomere shortening and apoptosis in telomerase-inhibited human tumor cells.

Authors:  X Zhang; V Mar; W Zhou; L Harrington; M O Robinson
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

5.  Short version of the CES-D (Burnam screen) for depression in reference to the structured psychiatric interview.

Authors:  A Tuunainen; R D Langer; M R Klauber; D F Kripke
Journal:  Psychiatry Res       Date:  2001-09-20       Impact factor: 3.222

6.  Reliability and validity of the Women's Health Initiative Insomnia Rating Scale.

Authors:  Douglas W Levine; Daniel F Kripke; Robert M Kaplan; Megan A Lewis; Michelle J Naughton; Deborah J Bowen; Sally A Shumaker
Journal:  Psychol Assess       Date:  2003-06

7.  Factor structure and measurement invariance of the Women's Health Initiative Insomnia Rating Scale.

Authors:  Douglas W Levine; Robert M Kaplan; Daniel F Kripke; Deborah J Bowen; Michelle J Naughton; Sally A Shumaker
Journal:  Psychol Assess       Date:  2003-06

8.  Effect of long-term hormone therapy on telomere length in postmenopausal women.

Authors:  Duk-Chul Lee; Jee-Aee Im; Jeong-Ho Kim; Hye-Ree Lee; Jae-Yong Shim
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

Review 9.  Sleep and sleep disturbances: biological basis and clinical implications.

Authors:  N Zisapel
Journal:  Cell Mol Life Sci       Date:  2007-05       Impact factor: 9.261

10.  Self-reported sleep complaints with long and short sleep: a nationally representative sample.

Authors:  Michael A Grandner; Daniel F Kripke
Journal:  Psychosom Med       Date:  2004 Mar-Apr       Impact factor: 4.312

View more
  5 in total

1.  Contributions of the Women's Health Initiative to understanding associations between sleep duration, insomnia symptoms, and sleep-disordered breathing across a range of health outcomes in postmenopausal women.

Authors:  Chloe M Beverly Hery; Lauren Hale; Michelle J Naughton
Journal:  Sleep Health       Date:  2019-11-04

2.  Sleep and affective disorders in relation to Parkinson's disease risk among older women from the Women's Health Initiative.

Authors:  Hind A Beydoun; Jiu-Chiuan Chen; Nazmus Saquib; Michelle J Naughton; May A Beydoun; Aladdin H Shadyab; Lauren Hale; Alan B Zonderman
Journal:  J Affect Disord       Date:  2022-06-22       Impact factor: 6.533

Review 3.  Effect of Physical Activity, Smoking, and Sleep on Telomere Length: A Systematic Review of Observational and Intervention Studies.

Authors:  Rocío Barragán; Carolina Ortega-Azorín; Jose V Sorlí; Eva M Asensio; Oscar Coltell; Marie-Pierre St-Onge; Olga Portolés; Dolores Corella
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

4.  The Impact of Concussion, Sport, and Time in Season on Saliva Telomere Length in Healthy Athletes.

Authors:  Matthew Machan; Jason B Tabor; Meng Wang; Bonnie Sutter; J Preston Wiley; Richelle Mychasiuk; Chantel T Debert
Journal:  Front Sports Act Living       Date:  2022-02-15

5.  Psychotropic medication use and Parkinson's disease risk amongst older women.

Authors:  Hind A Beydoun; Nazmus Saquib; Robert B Wallace; Jiu-Chiuan Chen; Mace Coday; Michelle J Naughton; May A Beydoun; Aladdin H Shadyab; Alan B Zonderman; Robert L Brunner
Journal:  Ann Clin Transl Neurol       Date:  2022-06-24       Impact factor: 5.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.